Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin Protocol for Prevention of Postpartum Hemorrhage in Elective Cesarean Sections
NCT02722356Completed
- Sponsor
- Carl R. Darnall Army Medical Center
- Start
- Apr 2016
- Primary completion
- Feb 2017
- Modality
- Peptides
01
Overview
Randomised, open-label trial of oxytocin in postpartum hemorrhage (PPH) (2 arms), sponsored by Carl R. Darnall Army Medical Center. Primary endpoints: Change in uterine tone at 9 minutes, Amount of time required to establish adequate uterine tone and 2 more. Started Apr 2016; status: completed.
02
Drugs
oxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT02722356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02722356.